Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Maria B. Karpova, Kazuyasu Fujii, Daniella Jenni, Reinhard Dummer & Mirjana Urosevic-Maiwald. (2011) Evaluation of lymphangiogenic markers in Sézary syndrome. Leukemia & Lymphoma 52:3, pages 491-501.
Read now
Read now
Claire Louise Cole & Gordon C Jayson. (2008) Oligosaccharides as anti-angiogenic agents. Expert Opinion on Biological Therapy 8:3, pages 351-362.
Read now
Read now
Articles from other publishers (17)
Wenda Huang, Zhaonian Hao, Feng Mao & Dongsheng Guo. (2022) Small Molecule Inhibitors in Adult High-Grade Glioma: From the Past to the Future. Frontiers in Oncology 12.
Crossref
Crossref
Juraj Sokol, Matej Hrncar, Frantisek Nehaj & Jan Stasko. (2019) Plasma Levels of Vascular Endothelial Growth Factor and Selected Hemostatic Parameters in Association With Treatment Response in Multiple Myeloma. Clinical and Applied Thrombosis/Hemostasis 25, pages 107602961882328.
Crossref
Crossref
Tieqiang Zhao, Wenyuan Zhao, Yuanjian Chen, Li Liu, Robert A. Ahokas & Yao Sun. (2013) Differential expression of vascular endothelial growth factor isoforms and receptor subtypes in the infarcted heart. International Journal of Cardiology 167:6, pages 2638-2645.
Crossref
Crossref
R. Timothy Bentley, Julie A. Mund, Karen E. Pollok, Michael O. Childress & Jamie Case. (2013) Peripheral blood biomarkers of solid tumor angiogenesis in dogs: A polychromatic flow cytometry pilot study. The Veterinary Journal 196:2, pages 236-240.
Crossref
Crossref
Lili Jiang, Libing Song, Jueheng Wu, Yi Yang, Xun Zhu, Bo Hu, Shi-Yuan Cheng & Mengfeng Li. (2013) Bmi-1 Promotes Glioma Angiogenesis by Activating NF-κB Signaling. PLoS ONE 8:1, pages e55527.
Crossref
Crossref
Shentong Fang, Heikki Repo, Heikki Joensuu, Arto Orpana & Petri Salven. (2011) High serum angiogenin at diagnosis predicts for failure on long-term treatment response and for poor overall survival in non-Hodgkin lymphoma. European Journal of Cancer 47:11, pages 1708-1716.
Crossref
Crossref
V. Chauhan, M. Howland, S. O’hara, L.A. Beaton, T. A. Burn, T.J. Stocki & R.C. Wilkins. (2012) Proteomic profiling to identify potential biomarkers of alpha-particle radiation exposure in human lung epithelial cells. Radioprotection 46:6, pages S377-S383.
Crossref
Crossref
Wael M. Swelam & Dalal M. Al Tamimi. (2010) Biological impact of vascular endothelial growth factor on vessel density and survival in multiple myeloma and plasmacytoma. Pathology - Research and Practice 206:11, pages 753-759.
Crossref
Crossref
Ludek Pour, Hana Svachova, Zdenek Adam, Martina Almasi, Lucie Buresova, Tomas Buchler, Lucie Kovarova, Pavel Nemec, Miroslav Penka, Jiri Vorlicek & Roman Hajek. (2009) Levels of angiogenic factors in patients with multiple myeloma correlate with treatment response. Annals of Hematology 89:4, pages 385-389.
Crossref
Crossref
Tamara Keith, Yuko Araki, Masaki Ohyagi, Maki Hasegawa, Kouhei Yamamoto, Morito Kurata, Yasunori Nakagawa, Kenshi Suzuki & Masanobu Kitagawa. (2007) Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia. British Journal of Haematology 137:3, pages 206-215.
Crossref
Crossref
Chuhl Joo LyuSun Young RhaSung Chul Won. (2007) Clinical Role of Bone Marrow Angiogenesis in Childhood Acute Lymphocytic Leukemia. Yonsei Medical Journal 48:2, pages 171.
Crossref
Crossref
Ioannis A. Avramis, Eduard H. Panosyan, Fred Dorey, John S. Holcenberg & Vassilios I. Avramis. (2006) Correlation between High Vascular Endothelial Growth Factor-A Serum Levels and Treatment Outcome in Patients with Standard-Risk Acute Lymphoblastic Leukemia: A Report from Children's Oncology Group Study CCG-1962. Clinical Cancer Research 12:23, pages 6978-6984.
Crossref
Crossref
Siqing Shan, Clay Flowers, Cathy D. Peltz, Heather Sweet, Norbert Maurer, Eun-Joo Gina Kwon, Ave Krol, Fan Yuan & Mark W. Dewhirst. (2005) Preferential extravasation and accumulation of liposomal vincristine in tumor comparing to normal tissue enhances antitumor activity. Cancer Chemotherapy and Pharmacology 58:2, pages 245-255.
Crossref
Crossref
Jurgen Becker, Jörg Wilting & Lothar L. Schweigerer. 2006. Apoptosis and Cancer Therapy. Apoptosis and Cancer Therapy
1087
1106
.
N. Sayinalp, H. Cinar, A. Uner, I. C. Haznedaroglu, Y. Buyukasik, H. Goker, S. Aksu, O. I. Ozcebe, S. Karakus, S. Kirazli & S. V. Dundar. (2004) Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders. Clinical and Laboratory Haematology 26:4, pages 265-268.
Crossref
Crossref
Francis J Giles, Julie M Vose, Kim-Anh Do, Marcella M Johnson, Taghi Manshouri, Gregory Bociek, Philip J Bierman, Susan M O’Brien, Hagop M Kantarjian, James O Armitage & Maher Albitar. (2004) Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin’s lymphoma or Hodgkin’s lymphoma. Leukemia Research 28:6, pages 595-604.
Crossref
Crossref
Maurizio Zangari, Elias Anaissie, Alison Stopeck, Alyssa Morimoto, Nguyen Tan, Jeffrey Lancet, Maureen Cooper, Alison Hannah, Guillermo Garcia-Manero, Stephan Faderl, Hagop Kantarjian, Julie Cherrington, Maher Albitar & Francis J. Giles. (2004) Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients with Refractory Multiple Myeloma. Clinical Cancer Research 10:1, pages 88-95.
Crossref
Crossref